E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary Group 2 innate lymphoid cells (ILC2s) are a specialized subset of lymphoid effector cells that are critically involved in allergic responses; however, the mechanisms of their regulation remain unclear. We report that conditional deletion of the E3 ubiquitin ligase VHL in innate lymphoid progenitors minimally affected early‐stage bone marrow ILC2s but caused a selective and intrinsic decrease in mature ILC2 numbers in peripheral non‐lymphoid tissues, resulting in reduced type 2 immune responses. VHL deficiency caused the accumulation of hypoxia‐inducible factor 1&agr; (HIF1&agr;) and attenuated interleukin‐33 (IL‐33) receptor ST2 expression, which was rectified by HIF1&agr; ablation or inhibition. HIF1&agr;‐driven expression of the glycolytic enzyme pyruvate kinase M2 downmodulated ST2 expression via epigenetic modification and inhibited IL‐33‐induced ILC2 development. Our study indicates that the VHL‐HIF‐glycolysis axis is essential for the late‐stage maturation and function of ILC2s via targeting IL‐33‐ST2 pathway. Graphical Abstract Figure. No Caption available. HighlightsVHL promotes maturation of ILC2s and lung inflammationVHL intrinsically regulates ILC2 developmentThe VHL‐HIF axis promotes the expression of the IL‐33 receptor ST2The PKM2‐pyruvate checkpoint inhibits epigenetic modification of the ST2 gene &NA; ILC2s are critically involved in allergic responses, but the mechanisms by which they are regulated remain unclear. Li et al. demonstrate that the VHL‐HIF axis is essential for ILC2 maturation and function via inhibition of glycolysis and induction of IL‐33 receptor expression. These findings have implications for identifying therapeutic targets for allergic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 2×
“HIF1a preferentially induces the expression of genes that are related to glycolytic pathway, which relies on a chain of catalytic reactions executed by multiple enzymes (Iyer et al., 1998).”
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“Under hypoxia conditions, HIFa cannot be hydroxylated; the stabilized HIFa dimerizes with HIF1b and then translocates into the nucleus to initiate the transcriptional regulation of diverse target genes by binding to hypoxia-response elements (HREs) (Schofield and Ratcliffe, 2004).”
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803 · cited 2×
“HIF1a-regulated glycolysis serves as a key metabolic checkpoint to cell fate determination between Th17 and Treg cells (Dang et al., 2011; Shi et al., 2011).”
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595 · cited 2×
“HIF1a-regulated glycolysis serves as a key metabolic checkpoint to cell fate determination between Th17 and Treg cells (Dang et al., 2011; Shi et al., 2011).”
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195 · cited 2×
“lymphocyte differentiation, and immune responses (Palazon et al., 2014).”
Metabolic regulation of immune responses
Ganeshan, K., & Chawla, A. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120236 · Cited by 926 · cited 1×
“HIF1a-mediated glycolysis has emerged as a key regulator for the metabolic checkpoint for the differentiation and activation of immune cells (Buck et al., 2015; Ganeshan and Chawla, 2014).”
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · cited 3×
“Loss of VHL enhances HIF1a-mediated CD8+ T cell glycolysis and facilitates the effector responses to persistent viral infection (Doedens et al., 2013).”
InfluentialS-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate
Tyrakis, P. A., Palazon, A., Macias, D., Lee, K. L., Phan, A. T., Veliça, P., You, J., Chia, G. S., Sim, J., Doedens, A., et al. (2016) · Nature · doi:10.1038/nature20165 · Cited by 433 · cited 2×
“2-hydroxyglutarate regulates CD8 T cell differentiation through modulation of histone and DNA demethylation (Tyrakis et al., 2016).”
Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
Yu, Y., Tsang, J. C. H., Wang, C., Clare, S., Wang, J., Chen, X., Brandt, C., Kane, L., Campos, L. S., Lu, L., et al. (2016) · Nature · doi:10.1038/nature20105 · Cited by 306 · cited 2×
“In addition, as PD-1hi ILC progenitors are recently identified (Yu et al., 2016), we used a PD-1hi progenitor population from control and Vhlfl/fl Zbtb16-cre mice for in vitro ILC2 differentiation and obtained similar results (Figures S4A and S4B).”
Cited by
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Tibbitt, C. A., Stark, J. M., Martens, L., Ma, J., Mold, J. E., Deswarte, K., Oliynyk, G., Feng, X., Lambrecht, B. N., De Bleser, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.014 · Cited by 260
Innate Lymphoid Cell Development: A T Cell Perspective
Cherrier, D. E., Serafini, N., & Di Santo, J. P. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.010 · Cited by 181
Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
Lewis, G., Wang, B., Shafiei Jahani, P., Hurrell, B. P., Banie, H., Aleman Muench, G. R., Maazi, H., Helou, D. G., Howard, E., Galle-Treger, L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02051 · Cited by 163
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
Metadata
- Authors
- Li, Q., Li, D., Zhang, X., Wan, Q., Zhang, W., Zheng, M., Zou, L., Elly, C., Lee, J. H., & Liu, Y.-C.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 48
- Issue
- 2
- Pages
- 258-270.e5
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2785820922
- Cited by
- 106
- References
- 10
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor. https://app.cochat.ai/papers/10.1016/j.immuni.2017.12.013
- The paper
- Li, Q., Li, D., Zhang, X., Wan, Q., Zhang, W., Zheng, M., Zou, L., Elly, C., Lee, J. H., & Liu, Y.-C. (2018). E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor. Immunity. https://doi.org/10.1016/j.immuni.2017.12.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.